Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions

Journal of Immunology

Volumn 160, Issue 12, 1998, Pages 6166-6171

  Hogaboam, Cory ^a   Kunkel, Steven L ^a   Strieter, Robert M ^a   Taub, Dennis D ^b   Lincoln, Pam ^a   Standiford, Theodore J ^a   Lukacs, Nicholas W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; HISTAMINE; STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CONTACT; CELL INTERACTION; CONTROLLED STUDY; FIBROBLAST; HISTAMINE RELEASE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; CELL MEMBRANE; CELLS, CULTURED; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; COCULTURE TECHNIQUES; CYTOKINES; FIBROBLASTS; HISTAMINE RELEASE; MAST CELLS; MICE; MICE, INBRED CBA; STEM CELL FACTOR;

EID: 0032526632     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Wasserman, S. I. 1989. Mast cell-mediated inflammation in asthma. Ann. Allergy 63:546.
2. Holgate, S. T. 1988. Mast Cells, Mediators and Disease. Klurg Academic Publishers, London.
3. Jordana, M. 1993. Mast cells and fibrosis: who's on first? Am J. Respir. Cell Mol. Biol. 8:7.
4. Mori, H., K. Kawada, P. Zhang, Y. Uesugi, O. Sakamoto, and A. Koda. 1991. Bleomycin-induced pulmonary fibrosis in genetically mast cell deficient WBB6F1-W/Wv mice and mechanism of the suppressive effect of transilast, an antiallergic drug inhibiting mediator release from mast cell, on fibrosis. Int. Arch. Allergy Appl. Immunol. 95:195.
5. Goto, T., D. Befus, R. Low, and J. Bienenstock. 1984. Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats. Am. Rev. Respir. Dis. 130:797.
6. Crimi, E., M. Chiaramondia, M. Milanese, G. A. Rossi, and V. Brusasco. 1991. Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen. Am. Rev. Respir. Dis. 144:1282.
7. Kung, T. T., D. Stelts, J. A. Zurcher, H. Jones, S. P. Umland, W. Kreutner, R. W. Egan, and R. W. Chapman. 1995. Mast cells modulate allergic pulmonary eosinophilia in mice. Am. J. Respir. Cell Mol. Biol. 12:404.
8. Undem, B. J., L. M. Lichtenstein, W. C. Hubbard, S. Meeker, and J. L. Ellis. 1994. Recombinant stem cell factor-induced mast cell activation and smooth muscle contraction in human blood. Am. J. Respir. Cell Mol. Biol. 11:646.
9. Selvan, R. S., J. H. Butterfield, and M. S. Krangel. 1994. Expression of multiple chemokine genes by a human mast cell leukemia. J. Biol. Chem. 269:13893.
10. Wilson S. D., V. K. Kuchroo, D. I. Israel, and M. E. Dorf. 1990. Expression and characterization of TCA3: a murine inflammatory protein. J. Immunol. 145:2745.
11. Russi, E. W., A. P. Perruchoud, L. D. Yerger, J. S. Stevenson, J. Tabak, B. Marchette, and W. M. Abraham. 1984. Late phase bronchial obstruction following nonimmunologic mast cell degranulation. J. Appl. Physiol. 57:1182.
12. Meininger, C. J., and B. R. Zetter. 1992. Mast cells and angiogenesis. Semin. Cancer Biol. 3:73.
13. Galli, S. J., J. R. Gordon, and B. K. Worshal. 1991. Cytokine production by mast cells and basophils. Curr. Opin. Immunol. 3:865.
14. Kulmburg, P. A., N. E. Huber, B. J. Scheer, M. Wrann, and T. Baumruker. 1992. Immunoglobulin E plus antigen challenge induces a novel intercrine/chemokine in mouse mast cells. J. Exp. Med. 176:1773.
15. Broide, D. H., C. M. Smith, and S. I. Wasserman. 1990. Mast cells and pulmonary fibrosis: identification of a histamine releasing factor in bronchoalveolar lavage fluid. J. Immunol. 145:1838.
16. Hawkins, R. A., H. N. Claman, R. A. Clark, and J. C. Steigerwald. 1985. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann. Intern. Med. 102:182.
17. Keith I., R. Day, S. Lemaire, and I. Lemaire. 1987. Asbestos-induced fibrosis in rats: increase inlung mast cells and autacoid contents. Exp. Lung Res. 13:311.
18. Iemura, A., M. Tsai, A. Ando, B. K. Wershil, and S. J. Galli. 1994. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am. J. Pathol. 144:321.
19. Huang, E. J., K. H. Nocka, J. Buck, and P. Besmer. 1992. Differential expression of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol. Biol. Cell 3:349.
20. Dastych, J., and D. D. Metcalf. 1994. Stem cell factor induces mast cell adhesion to fibronectin. J. Immunol. 152:213.
21. T. Kinashi, and T. A. Springer. 1994. Steel factor and c-kit regulate cell-matrix adhesion. Blood 83:1033.
22. Rennick, D., B. Hunte, G. Holland, and L. Thompson-Snipes. 1995. Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts. Blood 85:57.
23. Levi-Schaffer, F., and N. Riesel. 1989. In vitro regeneration of activated rat peritoneal mast cells cocultured with 3T3 fibroblasts. Cell. Immunol. 119:30.
24. Levi-Schaffer, F., R. Kelav-Appelbaum, and E. Rubinchik. 1995. Human foreskin mast cell viability and functional activity is maintained ex vivo by coculture with fibroblasts. Cell. Immunol. 162:211.
25. Levi-Schaffer, F., K. F. Austen, P. M. Gravallese, and R. L. Stevens. 1986. Coculture of interleukin-3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc. Natl. Acad. Sci. USA 83:6485.
26. Levi-Schaffer, F., and E. Rubinchik. 1995. Activated mast cells are fibrogenic for 3T3 fibroblasts. J. Invest. Dermatol. 104:999.
27. Galli, S. J., K. M. Zsebo, and E. N. Geissler. 1994. The kit ligand, stem cell factor. Adv. Immunol. 55:1.
28. Gordon, J. R., and S. J. Galli. 1994. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI: role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J. Exp. Med. 180:2027-2037.
29. Baggiolini, M. 1996. Eotaxin: a VIC (very important chemokine) of allergic inflammation? J. Clin. Invest. 97:587.
30. Rothenberg, M. E., R. Ownbey, P. D. Mehlhop, P. M. Loiselle, M. van de Rijn, J. V. Bonventre, H. C. Oettgen, P. Leder, and A. D. Luster. 1996. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin-5 in mice. Mol. Med. 2:334.
31. Lukacs, N. W., S. L. Kunkel, R. M. Stricter, H. Evanoff, M. L. Key, and D. D. Taub. 1996. The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation. Blood 87:2262.
32. Evanoff, H., M. D. Burdick, S. A. Moore, S. L. Kunkel, and R. M. Stricter. 1992. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol. Invest. 21:39.
33. Levi-Schaffer, F., E. T. Dayton, K. F. Austen, A. Hein, J. P. Caulfield, P. M. Gravallese, F. T. Liu, and R. L. Stevens. 1987. Mouse bone marrow-derived mast cells cocultured with fibroblasts: morphology and stimulation-induced release of histamine, leukotriene B4, C4, and prostaglandin D2. J. Immunol. 139:3431.
34. Wershil, B. K., M. Tsai, N. Geissler, K. M. Zsebo, and S. J. Galli. 1992. The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo: evidence that signalling through the c-kit receptor can induce expression of cellular activation. J. Exp. Med. 175:245.
35. Lukacs, N. W., S. L. Kunkel, R. M. Stricter, H. L. Evanoff, R. G. Kunkel, M. L. Key, and D. D. Taub. 1996. The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation. Blood 87:2262.
36. Lukacs, N. W., R. M. Stricter, P. M. Lincoln, E. Brownell, D. M. Pullen, H. J. Schock, S. W. Chensue, D. D. Taub, and S. L. Kunkel. 1996. Stern cell factor (c-kit ligand) influences eosinophil recruitment in allergic airway inflammation. J. Immunol. 156:3945.
37. Donaldson, L. E., E. Schmitt, J. F. Huntley, G. F. Newlands, and R. K. Grencis. 1996. A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth. Int. Immunol. 8:559.
38. Corrigan, C. J., and A. B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501.
39. Noguchi, H., G. M. Kephart, T. V. Colby, and G. J. Gleich. 1992. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am. J. Pathol. 140:521.
40. Fujimoto, K., K. KUDO, S. Yamaguchi, T. Honda, and Y. Matsuzawa. 1995. Eosinophil activation in patients with pulmonary fibrosis. Chest 108:48.
41. Jose, P. J., D. A. Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881.
42. Bartels, J., C. Schluter, E. Richter, N. Noso, R. Kulke, E. Christophers, and J. M. Schroder. 1996. Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression and identification of eotaxin sequence variants. Biochem. Biophys. Res. Commun. 225:1045.
43. +) mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 88:3195.
44. Gao, J. L., A. I. Sen, M. Kitaura, O. Toshie, M. E. Rothenberg, P. M. Murphy, and A. D. Luster. 1996. Identification of a mouse eosinophil receptor for the CC chemokine eotaxin. Biochem. Biophys. Res. Commun. 223:679.
45. Rothenberg, M. E., A. D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA 92:8960.
46. Tsai, M., T. Takeishi, H. Thompson, K. E. Langley, K. M. Zsebo, D. D. Metcalfe, E. N. Geissler, and S. J. Galli. 1991. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA 88:6382.